Search

everythinglearnresearchcommunity

for

Search:↓

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Tofacitinib may help treat severe hair loss, but more research is needed.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Apremilast did not work for treating severe alopecia areata.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Ruxolitinib helped a man regrow his beard after years of hair loss.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Finasteride helps female-pattern hair loss.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Both treatments for alopecia areata showed similar modest effectiveness.